<DOC>
	<DOCNO>NCT01178450</DOCNO>
	<brief_summary>The hypothesis study subtotal parathyroidectomy use minimally invasive surgery superior cinacalcet treatment persistent secondary hyperparathyroidism ( HPT ) post renal transplant , minimal morbidity significantly reduce cost treatment post transplant .</brief_summary>
	<brief_title>Parathyroidectomy vs Cinacalcet Treatment Secondary Hyperparathyroidism Post Renal Transplantation</brief_title>
	<detailed_description>Persistent hyperparathyroidism ( HPT ) hypercalcemia prevalent transplant ( affect 25 % patient ) negatively affect graft patient outcome . The subtotal parathyroidectomy standard treatment , although currently replace calcimimetic cinacalcet . Several study guarantee cinacalcet effective control hypercalcemia derive persistent HPT renal transplantation . However , maintenance treatment need hypercalcemia increase quickly treatment stop . This fact make increase lot cost transplantation patient . The hypothesis study subtotal parathyroidectomy minimally invasive surgery superior cinacalcet treatment persistent secondary HPT post renal transplant , minimal morbidity significantly reduce cost treatment transplantation .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Hyperparathyroidism , Secondary</mesh_term>
	<mesh_term>Cinacalcet Hydrochloride</mesh_term>
	<criteria>Functioning renal transplant , GFR ≥ 30 ml / min Time posttransplant &gt; 6 month PTHi &gt; 15pmol/L Calcium ≥2.63 mmol/L con phosphatemia ≤1.2 mmol/L Cervical scintigraphy Signed informed consent Contraindication surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Renal transplant</keyword>
	<keyword>Hypercalcemia</keyword>
</DOC>